Literature DB >> 2787171

Epidermal growth factor influences the developmental clock regulating maturation of the fetal lung fibroblast.

H C Nielsen1.   

Abstract

Growth factors may play a significant role in regulating the orderly progression of organ growth and differentiation during fetal development. We hypothesized that epidermal growth factor (EGF) would help regulate the development of surfactant synthesis in the fetal lung by influencing fibroblast-epithelial cell interactions. The effect of EGF (10 ng per ml) on the ability of the fetal lung fibroblast to produce fibroblast pneumonocyte factor (FPF) was studied in sex-specific fibroblasts cultured from day 16, day 17 or day 18 fetal mouse lungs. FPF which is normally not produced by day 16 fibroblasts, is found only in female fibroblasts on day 17, and then in both males and females on day 18. EGF advanced this pattern such that female fibroblasts produced activity on day 16 and fibroblasts from both sexes produced FPF activity on day 17 and day 18. Fibroblasts from an androgen receptor-deficient mouse model confirmed that the effect of EGF was sex-specific and related to the state of development of the fetal lung. We conclude that EGF advances the fetal lung fibroblast through specific stages of development. It appears, therefore, to help control the timing of the clock regulating fetal lung maturation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787171     DOI: 10.1016/0167-4889(89)90097-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  The ErbB4 receptor in fetal rat lung fibroblasts and epithelial type II cells.

Authors:  Washa Liu; Katja Zscheppang; Sandy Murray; Heber C Nielsen; Christiane E L Dammann
Journal:  Biochim Biophys Acta       Date:  2007-05-05

2.  Response to "Commentary on identity of fibroblast pneumocyte factor: rat vs. human".

Authors:  Heber C Nielsen; George King; Max H Cake
Journal:  Pediatr Res       Date:  2017-05-31       Impact factor: 3.756

3.  Lipopolysaccharide-induced injury is more pronounced in fetal transgenic ErbB4-deleted lungs.

Authors:  Andreas Schmiedl; Jan Behrens; Katja Zscheppang; Erkhembulgan Purevdorj; Dietlinde von Mayersbach; Andrea Liese; Christiane E L Dammann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-07-01       Impact factor: 5.464

4.  Neuregulin receptor ErbB4 functions as a transcriptional cofactor for the expression of surfactant protein B in the fetal lung.

Authors:  Katja Zscheppang; Thilo Dörk; Andreas Schmiedl; Frank E Jones; Christiane E L Dammann
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-11       Impact factor: 6.914

5.  Dihydrotestosterone potentiates EGF-induced ERK activation by inducing SRC in fetal lung fibroblasts.

Authors:  Matt K Lee; Susan M Smith; Sandy Murray; Lucia D Pham; Parviz Minoo; Heber C Nielsen
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

6.  ErbB4 regulates the timely progression of late fetal lung development.

Authors:  Washa Liu; Erkhembulgan Purevdorj; Katja Zscheppang; Dietlinde von Mayersbach; Jan Behrens; Maria-Jantje Brinkhaus; Heber C Nielsen; Andreas Schmiedl; Christiane E L Dammann
Journal:  Biochim Biophys Acta       Date:  2010-03-17

7.  Dissociated presenilin-1 and TACE processing of ErbB4 in lung alveolar type II cell differentiation.

Authors:  Najla Fiaturi; Anika Ritzkat; Christiane E L Dammann; John J Castellot; Heber C Nielsen
Journal:  Biochim Biophys Acta       Date:  2014-01-24

8.  Androgen regulation of epidermal growth factor receptor binding activity during fetal rabbit lung development.

Authors:  J M Klein; H C Nielsen
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

9.  Neuregulin-ErbB4 signaling in the developing lung alveolus: a brief review.

Authors:  Najla Fiaturi; John J Castellot; Heber C Nielsen
Journal:  J Cell Commun Signal       Date:  2014-05-31       Impact factor: 5.782

10.  miRNA regulated pathways in late stage murine lung development.

Authors:  Sana Mujahid; Tanya Logvinenko; Maryann V Volpe; Heber C Nielsen
Journal:  BMC Dev Biol       Date:  2013-04-24       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.